Diadema Partners LP Mannkind Corp Transaction History
Diadema Partners LP
- $391 Billion
- Q3 2025
A detailed history of Diadema Partners LP transactions in Mannkind Corp stock. As of the latest transaction made, Diadema Partners LP holds 212,475 shares of MNKD stock, worth $1.08 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
212,475
Previous 519,900
59.13%
Holding current value
$1.08 Million
Previous $1.94 Billion
41.32%
% of portfolio
0.29%
Previous 0.59%
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
255Shares Held
165MCall Options Held
2.76MPut Options Held
689K-
Black Rock Inc. New York, NY22.6MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$89.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY11.4MShares$57.8 Million1.01% of portfolio
-
State Street Corp Boston, MA10.7MShares$54.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.39MShares$37.4 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.3B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...